關(guān)鍵字:2010,CARI,2型糖尿病,腎功能評(píng)估,英文,GFR,AER,ACR,CKD,CVD,腎小球?yàn)V過(guò)率,尿蛋白肌酐比,蛋白尿,病理,頻率
簡(jiǎn)介:The NHMRC guideline covers issues related to the assessment and prevention of CKD in individuals with established type 2 diabetes. The NHMRC guidelines do not address the care of people with diabetes who have end-stage kidney disease (ESKD) or those who have a functional renal transplant. In addition, the present guideline does not provide recommendations regarding the management of individuals with established CKD, with respect to the prevention of other (non-renal) adverse outcomes, including retinopathy, hypoglycaemia, bone disease and cardiovascular disease.